OpenEvidence and Veeva Announce Open Vista Partnership

Core Insights - Veeva Systems and OpenEvidence have formed a long-term partnership to create and market Open Vista, which aims to enhance patient access to clinical trials and improve drug discovery through AI [1][2][7] - Open Vista will focus on connecting physicians and patients to relevant clinical trials and therapies, particularly for patients with serious illnesses who have limited treatment options [2] - The first product offerings from Open Vista are expected to be released in 2026 [2] Company Overview - Veeva Systems provides cloud-based software, data, and consulting services for the life sciences industry, serving over 1,500 customers, including major biopharmaceutical companies and emerging biotech firms [3] - OpenEvidence is recognized as the fastest-growing clinical decision support platform in the U.S., with over 40% of U.S. physicians actively using its services [4] - OpenEvidence is utilized by more than 10,000 hospitals and medical centers, emphasizing its role in aiding high-stakes clinical decisions based on peer-reviewed medical literature [4]